Artikelen bij SWD(2014)106 - Actieplan tegen HIV/AIDS in de EU en de buurlanden, 2014-2016 - Hoofdinhoud
Dit is een beperkte versie
U kijkt naar een beperkte versie van dit dossier in de EU Monitor.
dossier | SWD(2014)106 - Actieplan tegen HIV/AIDS in de EU en de buurlanden, 2014-2016. |
---|---|
document | SWD(2014)106 |
datum | 14 maart 2014 |
Brussels, 14.3.2014 SWD(2014) 106 final
COMMISSION STAFF WORKING DOCUMENT
Action Plan on HIV/AIDS in the EU and neighbouring countries:
2014-2016
EN
EN
COMMISSION STAFF WORKING DOCUMENT Action Plan on HIV/AIDS in the EU and neighbouring countries:
2014-2016
Contents
1. ) HIV/AIDS in the EU and neighbouring countries.........................................................................2
2. ) Commission Communication combating HIV/AIDS and action plan............................................2
3. ) Achievements of the EU policy framework on HIV/AIDS and the need for an increased focus ....3
4. ) Prolonging the Action Plan on HIV/AIDS....................................................................................4
1
1. ) HIV/AIDS in the EU and neighbouring countries
HIV infection remains of major public health importance in the EU and neighbouring countries. Contrary to the global trend, which shows an overall decline in new infections, the number of newly reported HIV cases in Europe is increasing. In 2012, more than 131.000 new HIV infections were reported in Europe and Central Asia, an 8% increase from 20111. A total of 29.000 cases were reported in the European Union and European Economic Area (EU/EEA) a 1% increase from 2011 and 102.000 cases from countries in Eastern Europe and Central Asia (a 9% increase from 2011).
The main HIV transmission mechanisms differ depending on the region. In the EU/EEA HIV is predominantly transmitted among men who have sex with men (MSM). HIV transmission through heterosexual contacts plays also an important role. In neighbouring countries the main transmission modes are heterosexual contacts, followed by injecting drug use (IDU). Besides MSM and IDUs other vulnerable groups at high risk of acquiring HIV infections include migrants and mobile populations, sex workers and prisoners.
Early diagnosis followed by counselling and treatment as well as preventive strategies play a crucial role in reducing the spread of the disease. Recent evidence suggests that early treatment has significant effects in terms of reducing the risk of further transmission as well as reducing the morbidity and mortality related to HIV/ADDS. However, in the EU/EEA 49% of people living with HIV/ADDS are diagnosed late in the course of the infection and the percentage is even higher in Eastern Europe and Central Asia. In addition, significant gaps in coverage of prevention measures and access to antiretroviral therapy remain in some eastern European countries. In several countries the high number of HIV/AIDS co-infections, such as tuberculosis, viral hepatitis, and sexually transmitted diseases other than HIV/AIDS are another serious concern.
2. ) Commission Communication combating HIV/AIDS and action plan
The Commission Communication on combating HIV/ADDS in the European Union and neighbouring countries, 2009-2013 2 provides a policy instrument to complement national policies on HIV/ADDS on European level and has been the basis for EU action since 2009. The overall objectives of the Communication are: (i) to contribute to reducing new HIV infections across all European countries by 2013, (ii) to improve access to prevention, treatment, care and support and (iii) improving the quality of life of people living with, affected by or most vulnerable to HIV/ADDS in the European Union and neighbouring countries.
The Communication is complemented by an operational action plan that contains 50 actions, which are structured in the following six key issue areas: (1) Politics, policies and involvement of civil society, wider society and stakeholders, (2) Prevention, (3) Priority regions, (4) Priority groups, (5) Improving the knowledge, (6) Monitoring and evaluation.
The action plan presented an initial set of actions arising from consultation with Commission services and external stakeholders, to be further developed along the lines of the political
1 European Centre for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2012. Stockholm; 2013
2 COM(2009) 569 final
2
actions presented in the Communication in cooperation with the HIV/ADDS Think Tank, the Civil Society Forum and external stakeholders.
Funding for the implementation of the Communication and action plan is provided through a range of mechanisms and instruments. These include the EU Health Programme, the EU Framework Programme for Research and Innovation, the Global Fund to Fight AIDS, Tuberculosis and Malaria, to which the EU is a major contributor, as well as EU Structural Funds, the Development Cooperation Instrument and the European Neighbourhood and Partnership Instrument.
3.) Achievements of the EU policy framework on HIV/AIDS and the need for an increased focus
Prime responsibility for protecting and improving the health of their citizens rests with the EU Member States and the neighbouring countries. However, Article 168 of the Treaty on the Functioning of the European Union explicitly acknowledges that Union action shall complement national policies, and shall be directed towards improving public health, preventing physical and mental illness and diseases, and obviating sources of danger to physical and mental health. As HIV/AIDS is a communicable disease it needs to be addressed by coordinating the efforts of national governments.
Upon request of the European Commission, the European Centre for Disease Prevention and Control (ECDC) prepared a monitoring report on the implementation of the Commission Communication and Action Plan for combating HIV/AIDS in 20133. The report highlights several achievements of the EU policy framework. For instance the Communication was identified as an important tool for galvanizing political leadership, which was instrumental in keeping HIV/AIDS on the agenda and has been used by civil society to frame debate at regional and national levels. The Think Tank and Civil Society Forum proved to be valuable platforms for policy dialogue and exchange of information and experience, and helped to promote Europe-wide action and effective communication.
Financial inputs to support the objectives of the Communication and action plan are considered to amount to approximately EUR 57.5 million annually. This funding contributed to the development of new treatments and prevention technologies through the EU Framework Programme for Research and Innovation, and supported the scaling up of HIV-related services in the most affected Member States, neighbourhood countries and the Russian Federation via Commission funding to the Global Fund. The EU Health Programme helped to strengthen national HIV responses focusing on populations most at risk, such as targeted prevention services and development of better approaches to service delivery for these population groups. Substantial improvements were also achieved in relation to epidemiological surveillance of HIV/AIDS and TB co-infection, and data reporting rates could be significantly enhanced. In Eastern Europe and Russia capacity building of non-state actors in the field of HIV has been supported through the Development Cooperation Instrument.
Furthermore, the report identifies additional areas requiring continued attention and areas where progress has been less pronounced. Amongst others these include: keeping HIV/AIDS
3 European Centre for Disease Prevention and Control. Monitoring implementation of the European Commission Communication and Action Plan for combating HIV/AIDS in the EU and neighbouring countries, 2009-2013. Final report Stockholm, 2013.
3
visibly high on the political agenda, tackling discrimination in relation to HIV/AIDS, achieving universal access to voluntary testing, treatment and care, implementation of harm reduction measures, and strengthening of behavioural surveillance. In May 2013 the high-level meeting on HIV and Human Rights 'Right to health, right to life', which was jointly organised by the European Commission and UNAIDS recognized the need for a continued and renewed commitment by the European Commission to keep HIV/ADDS high on the political agenda. The meeting also identified important areas addressed in the Communication and the action plan, which require further attention, and pointed towards new developments, which may warrant consideration in the future. Building on these findings, the HIV/ADDS Civil Society Forum stressed the importance of continued attention to certain critical aspects of HIV/AIDS policies and advocated the need for further action on HIV/AIDS.
This Staff Working Document prolongs the action plan thus providing continuity in EU Action beyond 2013. An independent external evaluation of the Communication and action plan is on-going, and due to be concluded in spring 2014. The results will contribute to the consideration of options for a possible future EU policy framework on HIV/AIDS.
4.) Prolonging the Action Plan on HIV/AIDS
A consultation process was carried out from August to November 2013, involving Commission services, the HIV/AIDS Think Tank, the Civil Society Forum, as well as WHO and UNAIDS. The suggestions and comments of most respondents converged around several key issues, which could be clustered into two groups.
Some issues and actions which are already addressed in the action plan require in particular continued and/or increased focus and attention in order to reach the objectives of the Communication. These include continued political leadership, addressing stigma and discrimination, treatment as prevention, as well as continued and improved attention to co-infections.
The Communication explicitly mentions political leadership as an important asset in the fight against HIV/AIDS. Political leadership helps to keep HIV/AIDS high on the political agenda, and has assisted civil society to frame debate at regional and national levels. Particularly political support at national and regional level should be further encouraged, for instance through existing policy dialogues between the EU (European Commission) and neighbouring countries.
One issue requiring greater attention is the need to address stigma and discrimination, including legal barriers that impede measures to fight HIV/AIDS. Given the limited EU competence in this field the Commission will work closely with civil society and Member States to achieve progress. In organising the high level meeting on HIV and Human Rights, as well as the workshop on 'Improving Access and Combating Discrimination in Healthcare with a focus on vulnerable groups'4, the Commission is already taking action. Building on these events a high-level meeting on access and antidiscrimination in health entitled 'Health in Europe - making it fairer' is scheduled to take place in March 2014.
HIV/AIDS co-infections such as tuberculosis (TB) and viral hepatitis are amid the leading causes of death for people living with HIV, particularly among drug users. For instance HIV is a major risk factor for developing TB, and TB is responsible for more than a quarter of
4 Within the Framework of the European Health Forum Gastein 2013
4
deaths among people living with HIV.5 Particularly in Eastern European countries efforts need to be continued to increase integrated prevention and treatment measures such as access to harm reduction methods, and antiretroviral treatment, particularly in prisons.
An increasing body of evidence confirms that treatment is effective in preventing HIV transmission, particularly in relation to heterosexual transmission6. This underlines not only the need for the strategic use of treatment, but also further increases the importance of early and increased testing particularly amongst high risk groups. These changes are for instance reflected in the consolidated WHO guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, which were released in June 2013, and should inform practice in Member States and neighbouring countries.
Finally, there is the need to stay aligned with regional action frameworks to facilitate synergies and maximise impact. For instance in 2011 WHO endorsed its European Action Plan for HIV/AIDS, 2012-2015, and currently the Global Fund is developing a Strategy on HIV/AIDS for Eastern Europe and Central Asia.
The consultation process also identified a number of other issues such as the need to provide targeted support to additional populations at risk, the development of integrated strategies to address HIV/AIDS and other sexually transmitted diseases, or the need to consider addressing other co-morbidities, in addition to TB and Hepatitis. These issues require further reflection and monitoring and will be further considered in discussions on a future EU policy framework on HIV/AIDS.
Financing of specific actions contained in this action plan will be subject to final approval of the Health Programme 2014-2020, and implementing decisions within the annual work plans. As such, the prolongation will not have any budgetary impact. The research objectives of the action plan will also be funded through the next EU programme for research and innovation, Horizon 2020, which was formally adopted in November 2013.
This table below presents the action plan arising from consultations with Commission services and external stakeholders. Actions are designed alongside the political actions of the Commission communication on combating HIV/AIDS in the European Union and the neighbouring countries, 2009-2013, and should contribute to achieving the envisaged targets. The action plan was originally developed in 2009. The below table maintains the original structure since it was acknowledged by many stakeholders that the majority of actions are still valid and relevant. Besides the key issue areas outlined in section 4 of this paper further changes were introduced mainly to specify and provide precision in terms of indicators and expected results. This action plan may need to be further developed and updated in cooperation with relevant stakeholders and in line with the results of the external evaluation of the Commission Communication on combating HIV/AIDS.
The geographical scope of the action plan includes EU Member States, EEA/EFTA countries and neighbouring countries, namely the EU Enlargement countries, the European Neighbourhood Policy (ENP) countries, in particular the Eastern ones bordering the EU, as well as the Russian Federation.
5 World Health Organization. European Action Plan for HIV/AIDS 2012-2015, Copenhagen 2011.
6 Cohen MS, Smith MK, Muessig KE, et. al. Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? The Lancet, published online October 21, 2013 http://www.melancet.com/journals/lancet/article/PnS0140-6736%2813%2961998-4/fulltext
5
European Union Action Plan on HIV/AIDS: prolongation 2014-2016
ISSUE | ACTION Bold = increased focus Normal = continued actions | PARTNERS INVOLVED IN REALISATION Bold = leading entities Italics = associated entities | TIME | INDICATOR(S) | EXPECTED RESULTS |
1. Politics, policies and involvement of civil society, wider society and stakeholders | |||||
HIV/AIDS as an issue requiring political attention | Promote HIV/AIDS and co-infections as public health and social concern Keep the topic on the political agenda particularly in countries with concentrated epidemics Use World AIDS day to raise awareness of the public and policy makers | Commission Member States Neighbouring countries Civil Society International organisations | Ongoing -2016 | Inclusion of HIV/AIDS cooperation in bilateral cooperation agreements and/or actions plans between the EU/Commission and neighbouring countries National Composite Policy Index Existence of one national HIV/AIDS plan, including surveillance monitoring and evaluation | Better use of existing policy dialogue mechanisms to promote effective political leadership particularly in countries with concentrated epidemics Better public awareness on HIV/AIDS Political support for the implementation of cost-effective, and evidence based measures to combat HIV/AIDS HIV is mainstreamed in EU policies |
Regular HIV/AIDS Think Tank and Civil Society Forum meetings including linkage to relevant other EU civil society fora | Commission Member States and neighbouring countries Civil Society International organisations | Ongoing -2016 | Number of meetings Dissemination and implementation of results from meetings Actions agreed and implemented | Know-how transfer Effective cooperation between all key players Joint actions carried out | |
Address HIV/AIDS and Human Rights: Tackle stigma, discrimination, and legal barriers in relation to HIV status, ensuring equal access and quality of | Member States and neighbouring countries Civil Society Commission | Ongoing-2016 | Level of discrimination in relation to HIV status, i.e. as monitored by the stigma index Monitoring of national policies and legislation in place (related to | Integrated antidiscrimination policies applied in EU and neighbouring states, Prohibition of discrimination in relation to HIV status in national legislation |
prevention, | HIV-specific | Better quality of life | |||
testing and | discrimination of | of people living with | |||
treatment | People living with | HIV/AIDS | |||
HIV and key | |||||
populations) | Promotion of a | ||||
public health | |||||
Number of actions | approach (as an | ||||
and measures | alternative to | ||||
taken to protect | criminalization) in | ||||
fundamental rights | managing | ||||
including expected | behaviours that put | ||||
results of initiatives | people at risk of HIV | ||||
supported at | acquisition | ||||
international level | |||||
Better awareness of | |||||
legal aspects of | |||||
discrimination | |||||
among Member | |||||
States and | |||||
integrated anti- | |||||
discrimination | |||||
policies with a | |||||
particular focus on | |||||
legislative solutions | |||||
and their correct | |||||
implementation | |||||
HIV/AIDS | Development, | Member States | Ongoing | National European | Scaling up of |
policies and | budgeting | and | -2016 | and international | development and |
strategies | implementation, | neighbouring | AIDS spending by | effective | |
monitoring and | countries | categories and | implementation of | ||
evaluation of | ECDC | financing sources | innovative HIV/AIDS | ||
targeted , | policies at regional, | ||||
regional, national | Civil Society | Number of | national and sub- | ||
and supranational | explicit | national level | |||
HIV/AIDS and co- | International | HIV/AIDS policies | leading to a | ||
infection policies | organisations | in place, scale and | reduction of HIV | ||
quality of | transmission | ||||
implementation | |||||
Sustainability of | |||||
funding for HIV | |||||
and co-infection | |||||
programmes | |||||
Civil society | Support of civil | National | Ongoing | NGOs and | Larger number of |
society through | authorities in the | -2016 | vulnerable groups | effective NGOs in | |
funding and legal | EU and | actively involved in | EU Member States | ||
support at EU and | neighbouring | planning, policy | and neighbouring | ||
national levels in | countries | formulation, | countries | ||
the EU and | budgeting, | ||||
neighbouring | Commission | monitoring | Higher degree of | ||
countries | &evaluation of HIV | NGO participation in | |||
Other | activities at EU, | decision making | |||
Involve and | stakeholders | national and | |||
consult civil | subnational levels | ||||
society including | |||||
people living with | Number of NGOs | ||||
HIV/AIDS and | which have access | ||||
other vulnerable | to specific funding | ||||
groups in | instruments (as a | ||||
development and | result of their |
7
implementation of | participation in | ||||
HIV policies | competitive calls for funding) | ||||
Ensure | |||||
sustainable | Percentage of | ||||
funding | NGOs with | ||||
opportunities for | projected income | ||||
NGOs in relevant | for the next 2/3/5 | ||||
EU instruments | years | ||||
The private | Intensify | Business & | Ongoing | Number of | Successful |
sector | cooperation with the private sector | Industry | -2016 | partnerships programmes | partnership projects |
and invite all | National | between | Solidarity with | ||
relevant | authorities | stakeholders | people living with | ||
stakeholders to | HIV | ||||
develop and | Commission | Number of ARV | |||
implement | price rebate | Affordable and | |||
initiatives | Civil Society | agreements | accessible HIV | ||
addressing | prevention | ||||
HIV/AIDS | measures including | ||||
including in the | condoms | ||||
workplace | Affordable and fair | ||||
Work with | ARV prices | ||||
pharmaceutical | |||||
industry to | Early treatment and | ||||
improve access | care, better | ||||
and availability of | treatment coverage, | ||||
HIV/AIDS | improved health | ||||
treatment across | status of people | ||||
the EU and | living with HIV | ||||
neighbouring | |||||
countries | Development of new business models to facilitate development and access to testing and treatment for HIV and co-infections |
8
2. Prevention | |||||
Targeted and | Identify | National / | Ongoing | Percentage of | Most at risk and |
combination | prevention needs | Regional | -2016 | most at risk groups | general populations, |
prevention | and integrated | authorities | reached with HIV- | and particularly | |
and | strategies based | prevention | young people better | ||
treatment | on current | Civil Society | programmes | informed about HIV | |
evidence and best | prevention | ||||
practice targeted | Commission | Number of health | measures | ||
to sub-national | facilities that | ||||
realities | ECDC | provide HIV testing | Reduction of new | ||
and counselling | HIV infections | ||||
Targeted | 2014- | services | |||
integrated | 2016 | Access to | |||
prevention and | comprehensive and | ||||
treatment to | Funding level of | integrated | |||
most at risk | integrated | prevention, and | |||
groups | prevention and | early testing | |||
(including sex | treatment | services and | |||
workers and | strategies for HIV- | commodities for | |||
prisoners) as | AIDS and co- | most at risk | |||
central focus of | infections including | populations | |||
national HIV- | proportion of | including sex | |||
AIDS and STI | funding targeting | workers and | |||
strategies | Ongoing | most at risk groups | prisoners | ||
-2016 | done in | ||||
Improve | collaboration with | ||||
exchange of best | civil society | ||||
practice, | organisations | ||||
information and | |||||
education on HIV | Number of national | ||||
and HIV | policy documents | ||||
prevention and | and guidelines in | ||||
treatment | which treatment as | ||||
prevention is | |||||
mentioned. | |||||
HIV | Apply evidence | ECDC, | Ongoing | Precise, | Improved |
transmission | based knowledge | -2016 | geographically | understanding of | |
and risk | from behavioural | EMCDDA | distinct | behavioural | |
behaviour | research in order | disaggregated | parameters | ||
to develop | Academia | data and resulting | contributing to the | ||
effective | policies | epidemic | |||
measures leading | Civil Society | ||||
to reduced risk | Number of | Adaptation of | |||
behaviour | Commission | developed | policies and | ||
guidelines and | prevention | ||||
Support the | 2014- | measures leading | measures | ||
enhancing of | 2016 | to reduced risk | |||
treatment | behaviour and | Reduction of new | |||
literacy | increased | HIV cases in most at | |||
treatment uptake | risk populations | ||||
and adherence. | |||||
Percentage of | |||||
health care | |||||
facilities providing | |||||
basic-level HIV | |||||
testing and | |||||
HIV/AIDS clinical | |||||
management |
9
Education | Better | Member States | Ongoing- | Number of | Reduced incidence |
awareness on | 2016 | awareness raising | of HIV and sexually | ||
sexual and | International | actions carried out | transmitted | ||
reproductive | Organisations | infections in | |||
health | particular among | ||||
Civil Society | young people | ||||
Commission | Less stigma and | ||||
discrimination of | |||||
groups at risk of HIV | |||||
and sexually | |||||
transmitted | |||||
infections | |||||
3. Priority regions and settings | |||||
Eastern | Reach universal | National | Ongoing | Domestic and | More people under |
European | access to | authorities | -2016 | international | treatment, decline of |
Member | voluntary testing, | HIV/AIDS | AIDS related deaths | ||
States, | treatment and | Civil society | spending | ||
Enlargement, | care | (including harm | Reduction of HIV | ||
ENP | Regional (Health) | reduction | and co-infections | ||
countries and | Introduction and | Networks (i.e. | measures) by | infection rate among | |
the Russian | implementation of | Northern | categories, | injecting drug users | |
Federation | effective harm | Dimension | financing source, | ||
reduction | Partnership in | and allocation to | Better health status | ||
measures for | Public Health and | priority groups. | of IDUs and | ||
prevention of HIV | Social Wellbeing) | prisoners and their | |||
and co-infections | Number of basic | partners | |||
Commission | activities and | ||||
Prevention and | programmes in | Decreased HIV and | |||
integrated HIV, | place, scale and | co-infections | |||
and co-infections | quality of | incidence in prisons | |||
treatment, | implementation, | ||||
including in | synergies | ||||
prisons and other | developed and | ||||
particular settings, | critical enablers | ||||
using innovative | funded | ||||
strategies to | |||||
reach target | Coverage of | ||||
groups, | integrated | ||||
particularly MSM, | prevention and | ||||
IDUs and Sex | treatment services | ||||
Workers | in prisons | ||||
Provision of | |||||
integrated HIV and | |||||
co-infections | |||||
services | |||||
Enlargement, | Promote | Commission | Ongoing | HIV/AIDS and co- | Improved national |
ENP | Cooperation on | -2016 | infections as an | HIV/AIDS and co- | |
countries and | HIV/AIDS and co- | Member States | agenda point in | infections plans for | |
the Russian | infections | and | regular health | prevention, | |
Federation | between the | neighbouring | policy dialogues | treatment, care and | |
EU, and | countries | with relevant | support | ||
neighbouring | Enlargement, | ||||
countries through | WHO | ENP countries, | Effective | ||
established policy | and the Russian | implementation of | |||
dialogue | UNAIDS | Federation | antidiscrimination | ||
mechanisms | policies | ||||
ECDC | Alignment of | ||||
Invitation and | actions with |
10
involvement of | international | |||
neighbouring | organizations | |||
countries in HIV | working on HIV- | |||
related meetings | AIDS to generate | |||
at EU level | synergies and | |||
maximize impact | ||||
Monitoring and | 2014- | |||
reporting | 2016 | Number of | ||
progress in | Enlargement and | |||
implementation | ENP annual | |||
of HIV-related | progress reports | |||
actions agreed | addressing | |||
in bilateral | HIV/AIDS and co- | |||
cooperation | infections | |||
agreements | ||||
and/or Action | ||||
Plans between | ||||
the EU and | ||||
neighbouring | ||||
countries | ||||
Strengthen the | ECDC, WHO- | Ongoing | Increased | Better surveillance, |
surveillance by | Euro, EMCDDA, | -2016 | interaction with | monitoring and |
stepping up | and involvement of | evaluation | ||
cooperation | Surveillance | Enlargement and | ||
between the | institutions in | ENP countries in | Improved integrated | |
ECDC, WHO- | Neighbouring | ECDC HIV/AIDS | HIV policies and | |
Euro, EMCDDA | countries and | and co-infection | programmes in the | |
and surveillance | Russian | programmes | EU and | |
authorities in | Federation | neighbouring | ||
Enlargement and | countries | |||
ENP countries | Commission | |||
and Russian | ||||
Federation | ENP partners | |||
Member States | ||||
Civil society | ||||
Exchange | Health | Ongoing | Number of | Better trained clinical |
programmes | Professional | -2016 | exchange | and social staff and |
between Member | associations | programmes | NGOs | |
States and | ||||
neighbouring | Member States | |||
countries for | ||||
training of medical | Neighbouring | |||
and social and | countries | |||
NGO staff | ||||
Civil Society | ||||
Industry |
11
4. Priority groups | |||||
Men having | Intensify the | Civil Society | Ongoing- | HIV incidence and | Adaptation in risk |
sex | promotion of safer | 2016 | prevalence | behaviour | |
with men | sex behaviour among MSM | Member States | among MSM | Reduction in HIV | |
Information on | Neighbouring | Changes | transmission among | ||
HIV prevention | countries | (increase/decreas | MSM | ||
integrated in | e) in rates of | ||||
sexual and | Commission | unsafe sex | Less stigma and | ||
reproductive | practices amongst | discrimination | |||
health education | ECDC | MSM | |||
and health care | Better knowledge on | ||||
services | sexual and reproductive health | ||||
Intensify | Member | Ongoing | Rate of late | Decrease of late | |
implementation of | States | -2016 | diagnoses among | diagnoses, timely | |
voluntary | MSM | start of treatment | |||
counselling and | Neighbouring | ||||
testing programs | countries | HIV testing rates | Reduction in HIV | ||
(VCT) among | among MSM | transmission among | |||
MSM | Health | MSM | |||
and other most at | Professional | Rate of unknown | |||
risk groups at | Associations | HIV status | |||
healthcare, and | and community | ||||
community based | based | Percentage of | |||
facilities, ensuring | organisations | MSM who | |||
effective link to | received an HIV | ||||
treatment and | Commission | test in the last 12 | |||
care | Civil Society | months and who know their results | |||
Increase | |||||
innovative testing | Percentage of | ||||
strategies | MSM reached | ||||
including outreach | with HIV | ||||
and peer support | programmes | ||||
to ensure access | |||||
to voluntary | |||||
counselling and | |||||
testing to most at | |||||
risk groups | |||||
Injecting drug | Implementation of | Member States | Ongoing | Coverage of harm | Decreased HIV |
users (IDUs) | risk and harm | -2016 | reduction | incidence among | |
reduction | Neighbouring | programmes, | people who inject | ||
measures to IDUs | countries | including syringe | drugs | ||
and their partners | exchange and | ||||
for prevention and | Civil Society | clean needles | Better access for | ||
treatment of HIV, | IDUs to harm | ||||
co-infections and | Commission | Coverage of drug | reduction measures, | ||
drug dependency | substitution, HIV | including clean | |||
in the community | ECDC | and co-infections | syringes and needles | ||
and prisons | treatment programmes Percentage of IDUs reached with HIV | Availability of specific, effective prevention programmes for IDUs and their |
12
programmes | partners | ||||
Migrants and | Targeted | Migrants and | Ongoing | Number of | Better information of |
mobile | prevention | ethnic minorities | -2016 | programmes and | migrants on risk |
populations7 | measures and | organisations | policies | prevention, HIV/AIDS | |
access to | developed and | and treatment, care | |||
services and | National | implemented | and support | ||
treatment for | authorities | ||||
migrants, and | Coverage of | Improved access and | |||
mobile | Commission | prevention | information on rights | ||
populations | services and | and possibilities for | |||
Civil society | treatment for | migrants and mobile | |||
Sustain and | 2014- | migrants, | population | ||
promote testing | 2016 | including | |||
and treatment | undocumented | ||||
migrants, and | |||||
mobile | |||||
populations | |||||
Abolish HIV | National | Ongoing | Number of | Non-discrimination of | |
associated travel | authorities | -2016 | countries/regions | migrants and mobile | |
and residence | with restrictions | populations with | |||
restrictions | regard to HIV status | ||||
5. Improving the knowledge | |||||
Research | Promote research | Commission | Ongoing- | Projects and | Moving towards a |
for the | 2016 | programmes | cure and | ||
development of | Member States | funded | development of new | ||
new, or better | or better diagnostic | ||||
prevention, | Industry | and preventive tools | |||
diagnostic and | and treatment | ||||
treatment | Research | options | |||
solutions for HIV, | institutions | ||||
co-infections and | |||||
co-morbidity | Public health | ||||
Institutions | |||||
Civil Society | |||||
In depth analysis | ECDC | 2014- | Studies, reports, | More adequate, | |
of trends and | 2016 | recommendations | evidence based | ||
dynamics in | EMCDDA | prevention | |||
sexual and drug | Number of actions | programmes, in | |||
use related risk | Academia | funded under EU | particular for risk | ||
behaviour | programmes | populations | |||
Commission | |||||
Ensure adequate | |||||
allocation of | Member States | ||||
funding for social | |||||
and behavioural | Civil society |
7 By 'migrants' we understand third-country nationals. By 'mobile populations' we understand EU citizens exercising their right to free movement. It also include ethnic minorities defined as, national minorities, in line with the Charter of Fundamental Rights prohibiting discrimination on any ground, such as sex, race, colour, ethnic or social origin, etc. http://ec.europa.eu/justice/fundamental-rights/minorities/index_en.htm.
13
research, socio- | ||||||
economic | ||||||
analysis | ||||||
Health care | Improve | Health | Ongoing- | Broad application | Timely diagnosis and | |
capacities and | professionals | 2016 | of international | more effective | ||
knowledge of | associations and | testing and | treatment solutions | |||
medical staff and | community | treatment | ||||
community based | based | guidelines | ||||
organisations with | organisations | |||||
regards to | ||||||
HIV/AIDS and co- | Member States | |||||
infections | ||||||
prevention, | WHO | |||||
testing, treatment | ||||||
and care including | Academia | |||||
larger | ||||||
dissemination of | Industry | |||||
clinical best | ||||||
practice | ||||||
Surveillance | Enhanced and | ECDC | Ongoing- | Comprehensive | Powerful | |
integrated | 2016 | overview of | epidemiology | |||
surveillance of all | EMCDDA | HIV/AIDS and co- | resulting in | |||
relevant aspects | infections in the | comprehensive and | ||||
on HIV/AIDS and | WHO | European region | evidence based | |||
CO | - infections | disaggregated | policies | |||
(including | Commission | data to identify | ||||
strengthened bio- | epidemiology | |||||
behavioural | Member States | including those | ||||
surveillance) | and neighbouring | linked to | ||||
countries | behavioural | |||||
issues | ||||||
Civil society | ||||||
6. Monitoring and | ||||||
evaluation | ||||||
Commitments of | Regular | ECDC | Ongoing | Progress reports | Realisation of | |
Dublin, Vilnius | monitoring | (Every 2 | commitments | |||
and Bremen | on scale and | WHO | years) | |||
declarations | quality | Improved quality of | ||||
of | Commission | life of people living | ||||
implementatio | and affected by HIV | |||||
n | UNAIDS | |||||
Reduced incidence | ||||||
Civil Society | ||||||
Member | ||||||
States and | ||||||
neighbouring | ||||||
countries | ||||||
Implementation | On-going | ECDC | Ongoing- | Progress reports | More effective | |
of this action | monitoring on | 2016 | policies, less new | |||
plan | scale and | Commission | HIV infections, better | |||
quality of | medical, social and | |||||
implementatio | Think Tank | legal conditions for | ||||
n | people affected by | |||||
HIV/AIDS Civil | HIV | |||||
Society Forum |
14